NCT01678170

Brief Summary

This trial is going to evaluate the value of blood-oxygen functional imaging technology in the diagnosis of breast diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2012

Completed
2 days until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2012

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

December 22, 2015

Status Verified

May 1, 2012

Enrollment Period

4.2 years

First QC Date

August 30, 2012

Last Update Submit

December 21, 2015

Conditions

Breast Diseases

Keywords

blood-oxygen functional imaging technologydiagnosis

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female with breast lump, received breast ultrasound and mammography

You may qualify if:

  • female older than 18 years breast lump received breast ultrasound and mammography

You may not qualify if:

  • After core-needle biopsy or resection After neoadjuvant chemotherapy, radiotherapy or endocrine therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Breast Imaging, Tianjin Medical University Cancer Hospital

Tianjin, Tianjin Municipality, 300060, China

RECRUITING

MeSH Terms

Conditions

Breast DiseasesDisease

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Peifang Liu, M.D.

    Department of Breast Imaging, Tianjin Medical University Cancer Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peifang Liu, M.D.

CONTACT

+86-22-23524536cjr.liupeifang@vip.163.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2012

First Posted

September 3, 2012

Study Start

September 1, 2012

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

December 22, 2015

Record last verified: 2012-05

Locations

CN(1)